National Cancer Survivors Day

Coping® is a proud sponsor and publisher of the exclusive coverage of National Cancer Survivors Day®.


Click here for Coping® magazine's Exclusive Coverage of National Cancer Survivors Day® 2017 (pdf).

Lymphoma Information

Return to Previous Page

Advice from a Teenage Cancer Survivor

by Carly Freels

Nearly 16,000 U.S. children and adolescents under the age of 20 are diagnosed with cancer each year. I am one of them. I was diagnosed with Hodgkin lymphoma when I was 17 years old.

Read More


The Daily Zoo

by Chris Ayers

When I started drawing an animal a day in 2006 on the one-year anniversary of my April 1st leukemia diagnosis (that’s right, I was told that I had cancer on April Fools’ Day!), I certainly had no idea that I would still be adding to this collection over three thousand days later. In fact, at that time, I wasn’t sure whether I would still be alive nine years later.

Read More


Get the Facts on Myelofibrosis

Myelofibrosis is a rare bone mar­row cancer in which the marrow is replaced by fibrous (scar) tissue. Myelofibrosis can occur on its own, called primary myelofibrosis, or as a progression of other bone marrow diseases. Myelofibrosis belongs to a group of closely related blood cancers, known as myeloproliferative neoplasms, in which the bone marrow cells that produce the body’s blood cells develop and function abnormally. The result is excessive fibrous tissue formation in the bone marrow, which can lead to severe anemia, weakness, fatigue, and an enlarged spleen and liver.

Read More


Follow-Up Care for Non-Hodgkin Lymphoma

by Katherine L. Byar, MSN, APN, BC, and Julie M. Vose, MD

Improvements in therapy have in­creased survival rates for many people with non-Hodgkin lymphoma. How­ever, NHL survivors are still at risk for developing late complications after treatment ends. Routine follow-ups are needed to assess any long-term side effects of therapy and to check for signs of cancer recurrence.

Read More


NIH Study Links Hodgkin Lymphoma Treatment to Possible Risk of Stomach Cancer

Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health.

Read More


Cutaneous Lymphoma Founda­tion

by Susan Thornton

The Cutaneous Lymphoma Founda­tion, a nonprofit patient advocacy organization, strives to support each person with cutaneous lymphoma by promoting awareness and education, advancing patient care, and facilitating research. Cutaneous lymphoma is a rare form of non-Hodgkin lymphoma that develops in the skin.

Read More


Survivor Winner Ethan Zohn on Surviving Hodgkin Lymphoma

by Jessica Webb Errickson

In 2002, Ethan Zohn overcame the elements and pushed his mind and body to the limit, outwitting, outplaying, and outlasting 15 fierce competitors to win the million-dollar prize on Survivor: Africa. Less than a decade later, Ethan would once again have to push his mind and body to the limit in order to survive.

Read More


Measuring Your CML Treatment Response

Your doctor needs to monitor your response to drug therapy for chronic myeloid leukemia with blood and bone marrow tests. This is a critically important step to under­take to bring your CML under control. Your test results help your doctor decide whether to increase your drug dose to try for a better response, de­crease or stop the drug briefly because of side effects, change to a different drug or drug combination to better con­trol the CML, or change to a different drug or drug combination to manage side effects.

Read More


Page 1 of 3  1 2 3 > 


eUpdate Sign up

Receive e-mails with links to the latest content on the Coping with Cancer website.

See past issues of eUpdate.

Follow us on Twitter

          Twitter icon

Like us on Facebook

          FaceBook icon

Subscribe to
Coping with Cancer magazine